Navigation Links
Analysis of the Current Economic Conditions Prevailing Across the Globe and Their Impact on the Pharmaceutical Industry

MUMBAI, December 10, 2013 /PRNewswire/ --

Bharat Book Bureau presents Pharmaceutical Business Confidence Report Q4 2013. This report analyzes pharmaceutical industry executives' views on the global economy, expectations on consumer confidence, supplier prices, key business concerns, and how executives' future investments are set to change in Q4 2013. This report also gives you access to regional analysis of industry outlook, industry and company growth prospects, future opportunities, staff hiring, and sales performance. Apart from providing access to the opinions and strategies of global pharmaceutical industry executives, it also examines their actions surrounding business priorities, threats and opportunities, and future investment areas over the next six months. (


Introduction and Landscape

Why was the report written?

This report is the result of an extensive survey drawn from our exclusive panel of leading global pharmaceutical industry executives. The report analyzes current economic conditions prevailing across the globe and their impact on the pharmaceutical industry, and Forecasts Company and industry growth prospects over the next six months. Furthermore, it also provides information about the impact of consumer confidence, supplier prices, and staff headcount likely to affect the investment decisions of the industry over the next six months.

What is the current market landscape and what is changing?

Overall, 66% and 50% of global pharmaceutical industry executives are optimistic about the future growth prospects of both their company and the industry over the next six months, respectively.

What are the key drivers behind recent market changes?

Optimism towards industry and company growth is driven by the improving global economic conditions, increasing in consumer spending, and the introduction of new products in the market.

What makes this report unique and essential to read?

"Pharmaceutical Business Confidence Report Q4 2013" is a new report that analyzes the industry sentiments globally on the latest economic and consumer issues and their impact upon investment decisions and growth prospects within the pharmaceutical industry. This report also examines the executive opinion about the current and future state of the economy and its retrospective effect on the industry. Furthermore, it analyzes the likely effect of supplier price changes, sales performance, and staff headcount within the industry over the next six months. In addition, it provides an overview of the key priorities, threats, and opportunities for the global pharmaceutical industry over the next six months.

Key Features and Benefits

  • Project industry trends and industry growth expectations in the next six months, and understand business confidence to make informed business decisions.
  • The report drives revenues by understanding future product investment areas and key growth regions.
  • Readers will be provided with a clear uncovering of the key challenges and opportunities, and identify the key priorities likely to affect the growth prospects of the industry.
  • The report clearly forecasts the change in supplier prices of various products, which are likely to influence the industry's growth prospects over the next six months.
  • Identifies the major changes in consumer confidence levels in the pharmaceutical industry over the next six months.

Key Market Issues

  • According to pharmaceutical industry respondents, the present economic conditions in the Middle East and Africa are deemed to be unfavorable.
  • New Government proposals/legislation, performance of North American economies, and the current state of the global economy are the key concerns among global pharmaceutical industry executives.
  • Overall, survey respondents forecast that supplier prices for semi-finished products will increase at an average of 3%, with those from Asia-Pacific expecting the biggest rise.
  • The majority of global pharmaceutical industry executives anticipate 'no change' in consumer confidence in the industry, in the next six months.
  • Overall, industry executives exhibit high levels of optimism towards company growth prospects compared to industry growth prospects, in the next six months

Key Highlights

  • Overall, 49% of survey respondents anticipate a positive change in the global economic outlook over the next six months.
  • Pharmaceutical industry executives plan to increase investments in the areas of new product development and marketing in the next six months.
  • Executives operating in Asia-pacific and North America anticipate the highest average increase, 5.1% and 4.0% respectively, in sales over the next six months.
  • Industry executives operating in Asia-Pacific and Europe anticipate an average increase of 2.7% and 2.5%, respectively, in their current workforce.
  • Executives operating across the globe consider 'increasing sales', 'improving operational efficiency', and 'new product development' as key priorities over the next six months.

Request for sample pages:

For more information on the report:

Related Reports:

Related Category:

About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:

Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773

SOURCE Bharat Book Bureau
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
2. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
3. Osteoporosis Drug Market- Global And China Market Analysis, Size, Trends And Forecast (2010-2015)
4. Large-Scale Meta-Analysis Shows Age Not a Social Barrier to Opioid Use and Misuse
5. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
6. Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
7. Demand for Product Pipeline Review and Analysis Rises in the Global Pharma Industry
8. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
9. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
10. Clinical Chemistry Market Report & Forecast (2012 - 2015): Global Analysis
11. Medical Diagnostic & Therapeutic Ultrasound Devices Market (2012 - 2017) - Global Trends & Competitive Analysis
Post Your Comments:
(Date:11/26/2015)... , Nov. 26, 2015 Research and ... the "Advanced Wound Care Market by Type (Dressings, ... End User (In-Patient Facility, Out-Patient Facility), and Geography - ... --> --> ... description, definition and forecast of the global advanced wound ...
(Date:11/26/2015)... 26, 2015 ... adds "Global Repaglinide Industry 2015 ... on China Repaglinide Market, 2010-2019" reports ... and information to its online business ... . --> ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Dr. John Pierce, Medical Director at the Ageless Forever clinic in Las ... Pro laser therapy cap. FDA cleared for safety and efficacy, the Capillus272 offers men ... surgery, prescription pills, or topical foams. , “Capillus272™ Pro is a home-use device ...
(Date:11/25/2015)... ... 2015 , ... On November 10, 2015, Bohrer Brady, LLC filed a class ... of a home health care worker who provided companionship services for the elderly, ill ... employed by Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an article ... being more and more widely heralded as a breakthrough for performing hernia repairs. The ... over traditional laparoscopic surgery is that it can greatly reduce the pain that a ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like to ... are invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses ... , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon ... programs, launches new Wimbledon Athletics Facebook page to educate the public, ... unsuspected cardiac abnormalities. About 2,000 people under the age of 25 die from ...
Breaking Medicine News(10 mins):